Physician profile
Guoxiang Chu
NPI 1295946580
$845.51
in general payments reported to CMS, 2019-2025
9 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2021: $24.02 · 2022: $39.36 · 2023: $73.74 · 2024: $169 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $267.39 | 2025 | Watchman Access System |
| Inari Medical, INC. | $168.90 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $136.41 | 2019-2022 | |
| Pfizer INC. | $80.66 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $73.74 | 2023 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.90 | 2019 | |
| Akcea Therapeutics, INC. | $27.11 | 2019 | |
| Abbott Laboratories | $24.02 | 2021 | |
| Bracco Diagnostics INC. | $21.38 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guoxiang Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.